Association of a Novel Polymorphism of the β2-Chimaerin Gene (CHN2) with Smoking

Journal of Investigative Medicine

Volumn 61, Issue 7, 2013, Pages 1129-1131

  Barrio Real, Laura ^a   Barrueco, Miguel ^a   González Sarmiento, Rogelio ^a   Caloca, Maria J ^b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b University of Valladolid   (Spain)

Author keywords

Addiction; CHN2; Polymorphisms; Smoking; 2 chimaerin

Indexed keywords

BETA 2 CHIMERIN; CHIMERIN; UNCLASSIFIED DRUG; BETA2 CHIMAERIN;

ADULT; ARTICLE; CHN2 GENE; CLINICAL EVALUATION; CONTROLLED STUDY; DEPENDENT PERSONALITY DISORDER; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SMOKING HABIT; TOBACCO DEPENDENCE; GENE FREQUENCY; GENOTYPING TECHNIQUE; REVIEW; RISK ASSESSMENT;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING;

EID: 84888232023     PISSN: 10815589     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e3182a32ff9     Document Type: Article

References (19)

1. Munafò MR, Clark TG, Johnstone EC, et al. The genetic basis for smoking behavior: A systematic review and meta-analysis. Nicotine Tob Res. 2004;6:583Y597.
2. Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci. 2001;2:119Y128.
3. Lind PA, Macgregor S, Vink JM, et al. A genomewide association study of nicotine and alcohol dependence in Australian and Dutch populations. Twin Res Hum Genet. 2010;13:10Y29.
4. Uhl GR, Liu QR, Drgon T, et al. Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Arch Gen Psychiatry. 2008;65:683Y693.
5. Yuan S, Miller DW, Barnett GH, et al. Identification and characterization of human beta 2-chimaerin: association with malignant transformation in astrocytoma. Cancer Res. 1995;55:3456Y3461.
6. Caloca MJ, Wang H, Kazanietz MG. Characterization of the Rac-GAP (Rac-GTPaseYactivating protein) activity of beta2-chimaerin, a 'non-rotein kinase C' phorbol ester receptor. Biochem J. 2003;375: 313Y321.
7. Caloca MJ, Delgado P, Alarcon B, et al. Role of chimaerins, a group of Rac-specific GTPase activating proteins, in T-cell receptor signaling. Cell Signal. 2008;20:758Y770.
8. Bruinsma SP, Baranski TJ. Beta2-chimaerin in cancer signaling: connecting cell adhesion and MAP kinase activation. Cell Cycle. 2007;6:2440Y2444.
9. Riccomagno MM, Hurtado A, Wang HB, et al. The RacGAP A2-Chimaerin selectively mediates axonal pruning in the hippocampus. Cell. 2012;149:1594Y1606.
10. Hashimoto R, Yoshida M, Kunugi H, et al. A missense polymorphism (H204R) of a Rho GTPase-activating protein, the chimerin 2 gene, is associated with schizophrenia in men. Schizophr Res. 2005;73:383Y385.
11. Moran LV, Sampath H, Kochunov P, et al. Brain circuits that link schizophrenia to high risk of cigarette smoking. Schizophr Bull. 2012 Dec 12. [Epub ahead of print].
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision. 4th ed. Washington, DC: American Psychiatric Association; 2000.
13. Liu QR, Drgon T, Johnson C, et al. Addiction molecular genetics: 639,401 SNP whole genome association identifies many ''cell adhesion'' genes. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:918Y925.
14. Desmet FO, Hamroun D, Lalande M, et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67.
15. Johnston MV. Clinical disorders of brain plasticity. Brain and Development. 2004;26:73Y80.
16. Novak G, Boukhadra J, Shaikh SA, et al. Association of a polymorphism in the NRXN3 gene with the degree of smoking in schizophrenia: A preliminary study. World J Biol Psychiatry. 2009;10:929Y935.
17. Docampo E, Ribasés M, Gratacos M, et al. Association of Neurexin 3 polymorphisms with smoking behavior. Genes Brain Behav. 2012;11:704Y711.
18. Kenney JW, Florian C, Portugal GS, et al. Involvement of hippocampal jun-N terminal kinase pathway in the enhancement of learning and memory by nicotine. Neuropsychopharmacology. 2009;35:483Y492.
19. Notcovich C, Diez F, Tubio MR, et al. Histamine acting on H1 receptor promotes inhibition of proliferation via PLC, RAC, and JNK-dependent pathways. Exp Cell Res. 2010;316:401Y411.